tiprankstipranks

New Portfolio Jan 2023 - New Portfolio

Assen

New Portfolio Jan 2023
Individual Investor
Ranked #539,954 out of 858,885 TipRanks' Investors
Success Rate
39%
44 out of 113
profitable transactions
Average Return
-3.53%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 1.38%
6-Month Return▼ 3.96%
12-Month Return▲ 10.33%
YTD Return▼ 6.54%
Total Return▲ 2.44%

Best Trade

Opened at
Closed at-
Gain▲ 304.80%

Bio

LT focused portfolio with primary investment in EU based companies

Performance

12.88%0-12.88%
▲ 12.88%
▲ 3.56%
▲ 0.74%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 3.59%
Oct 2025
▼ 3.68%
▲ 0.19%
▲ 0.40%
Nov 2025
▼ 0.10%
▲ 0.08%
▼ 0.20%
Dec 2025
▲ 4.06%
▲ 1.47%
▲ 0.75%
Jan 2026
▼ 1.12%
▼ 0.86%
▼ 1.04%
Feb 2026
▲ 0.60%
▼ 4.94%
▼ 10.00%
Mar 2026
▲ 4.89%
▲ 4.48%
▲ 4.16%
Apr 2026
TipRanks AverageS&P 500Investor Portfolio
▲ 12.88%▲ 3.56%▲ 0.74%
▲ 10.96%▲ 2.38%▲ 3.59%
▼ 3.68%▲ 0.19%▲ 0.40%
▼ 0.10%▲ 0.08%▼ 0.20%
▲ 4.06%▲ 1.47%▲ 0.75%
▼ 1.12%▼ 0.86%▼ 1.04%
▲ 0.60%▼ 4.94%▼ 10.00%
▲ 4.89%▲ 4.48%▲ 4.16%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Sanofi
0%
▼ 7.48%
4
Sell
Aug 17, 2025
Kering SA
0%
▼ 23.94%
6
Sell
Aug 17, 2025
Novo Nordisk
16.15%
▼ 52.86%
8
Buy
Aug 17, 2025
The Estée Lauder Companies
0%
▼ 33.64%
7
Sell
Aug 17, 2025
Tesla
9.01%
▲ 41.56%
3
Buy
Aug 17, 2025
Nvidia
9.74%
▲ 125.26%
5
Buy
Aug 17, 2025
EssilorLuxottica SA
4.81%
▼ 10.96%
3
Buy
Aug 17, 2025
LVMH Moet Hennessy Louis Vuitton
12.15%
▼ 16.73%
4
Buy
Aug 17, 2025
Barry Callebaut AG
0%
▼ 11.38%
2
Sell
Aug 17, 2025
Eli Lilly & Co
8.04%
▲ 33.13%
1
Open
Aug 17, 2025
Remy Cointreau
1.18%
▼ 59.10%
7
Buy
May 14, 2025
Brown Forman A
0.77%
▼ 32.88%
4
Buy
May 14, 2025
L'Oreal
3.61%
▼ 11.02%
2
Buy
May 14, 2025
TotalEnergies SE
7.91%
▲ 44.07%
2
Buy
May 14, 2025
Air Liquide
▲ 13.26%
4
Close
Sep 27, 2024
Ferrari
0%
▼ 21.69%
2
Sell
Sep 27, 2024
AXA SA
0%
▲ 28.56%
2
Sell
Sep 27, 2024
Alibaba
0%
▲ 49.36%
2
Sell
Sep 27, 2024
Compagnie Financiere Richemont SA
▼ 5.60%
2
Close
Sep 27, 2024
Bristol-Myers Squibb
0%
▲ 47.99%
2
Sell
Sep 27, 2024